Huaxia Eye Hospital Group Co.,Ltd. (SHE:301267)
China flag China · Delayed Price · Currency is CNY
14.96
-0.13 (-0.86%)
Oct 29, 2026, 4:00 PM EDT

Huaxia Eye Hospital Group Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
4,2094,1394,0274,0133,2333,064
Revenue Growth
2.23%2.79%0.34%24.12%5.51%21.86%
Gross Profit
1,8001,7831,7681,9581,5461,403
Operating Income
623.51615.23594.57878.8724.3649.04
Net Income
473.15440.65428.64665.93513.82454.92
Earnings Per Share
0.560.530.510.790.670.61
EPS Growth
6.30%3.92%-35.44%17.91%10.43%35.82%

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
4,0373,7284,1584,2404,143953.42
Total Debt
1,0781,139975.6736.45720.01657.91
Net Cash (Debt)
2,9592,5893,1823,5033,423295.51
Net Cash Growth
3.46%-18.64%-9.17%2.35%1058.22%-41.52%
Net Cash Per Share
3.523.113.794.164.460.39

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
930.3867.58820.3961.24769.98798.02
Capital Expenditures
-202.58-231.99-279.59-448.43-235.31-173.63
Free Cash Flow
727.72635.59540.71512.81534.68624.38
Free Cash Flow Growth
16.44%17.55%5.44%-4.09%-14.37%46.11%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
42.76%43.07%43.90%48.80%47.83%45.79%
Operating Margin
14.82%14.86%14.77%21.90%22.40%21.18%
Pretax Margin
14.95%13.86%13.98%21.29%20.22%19.00%
Profit Margin
11.24%10.65%10.64%16.59%15.89%14.85%
FCF Margin
17.29%15.36%13.43%12.78%16.54%20.38%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Jan '23
Dividend Per Share
0.2600.2600.2200.1100.187
Dividend Per Share Growth
18.18%18.18%100.00%-41.08%-
Dividend Yield
1.74%1.45%1.15%0.34%0.38%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
26.6133.9737.0240.4879.68-
Forward PE
23.7529.9720.3334.32--
P/FCF Ratio
17.1123.5529.3552.5676.57-
PS Ratio
2.963.623.946.7212.66-